Humabiologics

Humabiologics, Inc. is a biotechnology company advancing regenerative medicine through high-quality, native human-derived biomaterials. Founded in 2018, the company ethically sources donated human tissue to create clinically relevant materials such as collagen, gelatin, and extracellular matrices that support applications including tissue engineering, wound healing, drug discovery, and 3D bioprinting.

Now in the Innovation Quarter, Humabiologics is expanding the development and early-stage manufacturing of first-in-market, human collagen-based medical devices while collaborating with regional research and clinical partners to help translate scientific discovery into patient-focused solutions.